Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
Mobia Medical (Nasdaq: MOBI) said CMS proposed keeping CPT 64568 for its Vivistim procedure in New Technology APC 1580 for CY2027, with an outpatient hospital payment rate of about $45,000, unchanged from CY2026. CMS plans to issue the final OPPS rule in November, effective Jan. 1, 2027.
How this was made
The 30-second read
Why it matters
If finalized as proposed, hospitals can plan 2027 expansion with more predictable reimbursement economics, supporting commercial momentum. However, the final OPPS rule in November is the decisive catalyst.
Market read
A concrete CMS proposal preserves 2027 reimbursement economics for Vivistim, lowering adoption risk until the final OPPS rule.
What to watch
Hospital adoption depends not just on the APC assignment but also on utilization, contracting, and any future CMS coding/coverage changes beyond OPPS payment.
Background
Mobia’s Vivistim procedure uses CPT 64568 and is currently assigned to New Technology APC 1580; CMS proposes maintaining that assignment for CY2027.
Ticker impact
Mobia says CMS proposed to keep CPT 64568 (Vivistim) in New Technology APC 1580 for CY2027 at ~$45,000, unchanged from 2026.
Moderately positive bias for MOBI as reimbursement stability supports adoption expectations into 2027; final OPPS rule remains the key swing factor.
The article is a primary regulatory proposal with a specific payment-rate implication, but it is not final and could change in the November rulemaking.
Market effects
Reimbursement stability for a neurostimulation stroke-recovery procedure can support sentiment toward other reimbursement-dependent medtech/neuromodulation names.
Primarily US Medicare/Medicaid hospital outpatient reimbursement dynamics.
Limited direct global impact; US reimbursement policy is the main driver.
Counterpoint
Because this is only a CMS proposed rule, the market may overreact; the final OPPS rule could reassign the code or adjust payment rates.
Key entities
- companyMobia Medical, Inc.
Commercial-stage medical device company marketing the Vivistim Paired VNS System for chronic ischemic stroke upper-limb recovery.
- regulatorCMS (Centers for Medicare and Medicaid Services)
Proposed to maintain CPT 64568 under New Technology APC 1580 for CY2027 with an associated hospital outpatient payment rate of about $45,000.
- medical_procedureCPT Code 64568 / Vivistim procedure
The procedure code whose OPPS APC assignment determines hospital outpatient reimbursement economics.
